To compare efficacy of two drugs in maintaining pupillary dilatation during Phaco emulsification surgery.
- Conditions
- Health Condition 1: null- Patients with Cataract
- Registration Number
- CTRI/2018/01/011277
- Lead Sponsor
- I
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 160
Cataract patients 40 yrs age and above
1)Diabetes Mellitus and Hypertension
2)Ocular co-morbidities like injury, uveitis and local pupillary abnormalities
3)Any previous intraocular surgery
4)Pseudo-exfoliation
5)Eye with <6.00 mm pupil size at the baseline
6)Intra-operative surgical complications such as posterior capsular tear,
vitreous loss, nucleus drop, zonular dehiscence
7)Pregnant and nursing mothers.
8)Knowledge or suspicion of allergy or hypersensitivity to preservatives, steroids, topical NSAIDS or any other component of study medications.
9)Use of any eye medications except artificial tear drops 3 weeks prior to inclusion in the study.
10)Use of alpha 1 receptor blocker (Tamsulosin) or tricyclic antidepressants (TCA) that may induce intra-operative miosis.
11)Use of systemic NSAIDS or steroids within 4 weeks prior to inclusion in the study.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Measuring difference in reduction of papillary size using two different drugs. <br/ ><br>Timepoint: At beginning of surgery, After phacoemulsification, After completion of surgery
- Secondary Outcome Measures
Name Time Method ilTimepoint: Nil